Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.23.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenues:    
License and other revenues $ 1,414 $ 3,000
Expenses:    
Royalties 450
Research and development 28,965 38,726
General and administrative 17,256 21,644
Impairment of goodwill 32,466
Impairment of licensed technology 1,355
Impairment of right-of-use lease assets 2,511
Impairment of construction-in-progress 1,792
Total expenses 52,329 92,836
Loss from operations (50,915) (89,836)
Gain on settlement with licensor 6,743
PPP loan payable forgiveness income 1,758
Interest income 431 40
Interest expense (736) (3,656)
Change in fair value of warrant liabilities 11,383
Other income 141 15
Net loss (39,696) (84,936)
Deemed dividends related to Series A and Series B Convertible Redeemable Preferred Stock (3,782)
Net loss attributable to Common Shareholders $ (43,478) $ (84,936)
Basic and diluted loss per common share $ (5.53) $ (21.57)
Weighted average number of common shares outstanding – basic and diluted 7,861,515 3,937,676
Other comprehensive income (loss):    
Change in unrealized gains (losses) related to available-for-sale debt securities $ (99) $ 9
Foreign currency translation adjustments (3) (26)
Comprehensive loss $ (43,580) $ (84,953)